NYSE:CVS - CVS Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$69.89 +0.36 (+0.52 %)
(As of 02/19/2019 11:27 AM ET)
Previous Close$69.53
Today's Range$69.28 - $70.1350
52-Week Range$60.14 - $82.15
Volume4.09 million shs
Average Volume9.76 million shs
Market Capitalization$71.20 billion
P/E Ratio11.85
Dividend Yield2.95%
Beta1.03
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
CUSIP12665010
Phone401-765-1500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$184.77 billion
Cash Flow$8.8580 per share
Book Value$37.21 per share

Profitability

Net Income$6.62 billion

Miscellaneous

Employees160,000
Outstanding Shares1,018,799,000
Market Cap$71.20 billion
OptionableOptionable

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health declared a quarterly dividend on Thursday, January 3rd. Investors of record on Friday, January 25th will be given a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date is Thursday, January 24th. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) issued its quarterly earnings data on Wednesday, August, 8th. The pharmacy operator reported $1.69 earnings per share for the quarter, topping analysts' consensus estimates of $1.61 by $0.08. The pharmacy operator earned $46.71 billion during the quarter, compared to analysts' expectations of $46.34 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The business's revenue for the quarter was up 2.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.33 earnings per share. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 20th 2019. View Earnings Estimates for CVS Health.

How can I listen to CVS Health's earnings call?

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

What price target have analysts set for CVS?

15 analysts have issued 1 year price objectives for CVS Health's shares. Their forecasts range from $75.00 to $104.00. On average, they expect CVS Health's stock price to reach $91.7857 in the next year. This suggests a possible upside of 31.3% from the stock's current price. View Analyst Price Targets for CVS Health.

What is the consensus analysts' recommendation for CVS Health?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Has CVS Health been receiving favorable news coverage?

Headlines about CVS stock have been trending positive recently, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CVS Health earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned media stories about the pharmacy operator a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near term.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 14,420,741 shares, an increase of 35.1% from the January 15th total of 10,671,652 shares. Based on an average daily trading volume, of 9,924,659 shares, the days-to-cover ratio is currently 1.5 days. Currently, 1.1% of the shares of the company are short sold. View CVS Health's Current Options Chain.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, CEO & Director (Age 63)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 63)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel (Age 55)
  • Ms. Eva C. Boratto, Exec. VP & CFO (Age 52)
  • Mr. James D. Clark, Sr. VP, Controller & Chief Accounting Officer (Age 54)

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.12%), Oregon Public Employees Retirement Fund (2.46%), Northern Trust Corp (1.76%), Geode Capital Management LLC (1.62%), Bank of New York Mellon Corp (1.43%) and Parnassus Investments CA (1.35%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which major investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including American International Group Inc., First American Bank, Parnassus Investments CA, CI Investments Inc., Harris Associates L P, Kiltearn Partners LLP, DNB Asset Management AS and State Treasurer State of Michigan. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

Which major investors are buying CVS Health stock?

CVS stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, BlackRock Inc., Geode Capital Management LLC, Epoch Investment Partners Inc., Northern Trust Corp, Dimensional Fund Advisors LP, Diamond Hill Capital Management Inc. and Bank of New York Mellon Corp. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $69.89.

How big of a company is CVS Health?

CVS Health has a market capitalization of $71.20 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 160,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is http://www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (NYSE CVS)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  1,080 (Vote Outperform)
Underperform Votes:  590 (Vote Underperform)
Total Votes:  1,670
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel